127 results
-
Code of Practice for Veterinary Radiation: Draft for consultation
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of irradiating apparatus and radioactive material for veterinary diagnosis, research or therapy purposes. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is issued. The purpose of this document is to provide suggestions to assist in that consultation process. The Introduction to the Code, Key roles,... MoreOpened 4 October 2019 -
Code of Practice for Unsealed Radioactive Material: Draft for consultation
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of unsealed radioactive material for non-medical purposes. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is issued. The purpose of this document is to provide suggestions to assist in that consultation process. The Introduction to the Code, Key roles, Definitions, training, annaul limits on intake... MoreOpened 4 October 2019 -
Code of Practice for Sealed Radioactive Material: Draft for consultation
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of sealed radioactive material for non-medical purposes. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is issued. The purpose of this document is to provide suggestions to assist in that consultation process. The Introduction to the Code, Key roles, Definitions, training and sources/devices sections... MoreOpened 4 October 2019 -
Code of Practice for Irradiating Apparatus: Draft for consultation
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of non-medical irradiating apparatus. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is issued. The purpose of this document is to provide suggestions to assist in that consultation process. The Introduction to the Code, Key roles, Definitions, training and equipment sections set out the proposed... MoreOpened 4 October 2019 -
Maternal Fetal Medicine (MFM) Action Plan
Consultation on the MFM Action Plan MoreOpened 20 September 2019 -
Participate. Shape the future - Cancer Action Plan 2019-29
66 people are told they have cancer every day. Most New Zealanders will be impacted by cancer in their lifetime – either directly, or through friends or family members affected by cancer. Right now, we are finalising the New Zealand Cancer Action Plan 2019-2029. We want to hear what matters most to you. MoreOpened 18 September 2019 -
New Zealand Cancer Action Plan 2019–2029
Tēnā koutou katoa, We are seeking your feedback on the New Zealand Cancer Action Plan 2019–2029 (PDF, 1.5 MB) (the Plan). The Ministry of Health has engaged with a number of cancer-sector stakeholders in the development of the Plan. The following questions about the Plan are designed to help you prepare your feedback. Not all areas of the Plan will be included in the questions as: the Ministry will or has already engaged some sections through a separate... MoreOpened 1 September 2019 -
HISO 10050.2:2019 Maternity Care Summary Standard – Draft for public comment
To provide high quality maternity care in New Zealand we need to underpin maternity practice with information that supports the care of women, babies and their family/whānau, continuity of care, best practice, and analytics. The HISO 10050.2:2019 Maternity Care Summary Standard is designed to ensure that information related to maternity care is consistently recorded. Standardised data will enable services to be meaningfully benchmarked against each other. A meaningful data set... MoreOpened 23 July 2019 -
Changes to the prescribing restrictions for riluzole
Riluzole is a glutamate agonist used in the management of amyotrophic lateral sclerosis (ALS). Riluzole is a prescription medicine approved under section 23 of the Medicines Act 1981. The following condition regarding prescriber access to this medicine applies. MoreOpened 11 July 2019 -
Medicinal Cannabis Scheme consultation
The Government has committed to establishing a Medicinal Cannabis Scheme to improve access to quality medicinal cannabis products through: enabling the commercial cultivation of medicinal cannabis and the manufacture of medicinal cannabis products in New Zealand setting standards for medicinal cannabis products so that medical practitioners can prescribe them with more confidence. A regulatory system, with controls on the cultivation of cannabis and the... MoreOpened 10 July 2019 -
Code of Practice for the Security of Radioactive material: Draft for Consultation
The Radiation Safety Act 2016 came fully into force on 7 March 2017. The Act is administered by the Ministry of Health’s Office of Radiation Safety. The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the requirements are often very technical. The Act therefore authorises the issuing of codes of practice to set out more detailed requirements relating to individual areas of practice. This code relates to... MoreOpened 2 July 2019 -
Proposed Lung Cancer Quality Performance Indicators: Draft descriptions for review
The Ministry and the National Lung Cancer Working Group (the Working Group) have worked together to develop a set of proposed quality performance indicators (QPIs) for lung cancer. The proposed indicators have been selected to measure performance and drive quality improvement in lung cancer diagnosis and treatment services . The Working Group has identified a set of 19 QPIs that measure the quality of care and outcomes for people with lung cancer in New Zealand and support continuous... MoreOpened 1 July 2019 -
Well Child Tamariki Ora Review online feedback
Consultation overview: The Well Child Tamariki Ora Programme (WCTO) provides universal child health services and checks to tamariki and their whānau. It is a key contributor to the Government’s cross-agency work to improve child Wellbeing, and is a priority within the government to improve child wellbeing. To find out more information about the programme and review please see the related links below. The Ministry of Health is reviewing and improving the... MoreOpened 28 June 2019 -
Proposed warning statements for substances (eg, allergens) in medicines that may cause undesirable reactions
This Medsafe consultation proposes labelling requirements for substances/groups of substances in medicines and related products that may cause an undesirable reaction (eg, allergies) in some people. Unlike foods, most medicines and related products are not required to list all the ingredients that are included in the medicine on the label. The active ingredient will always be on the medicine label, but only some inactive ingredients, also called excipients, must be on the label.... MoreOpened 27 June 2019 -
Child New Zealand Health Survey Stakeholder Feedback Questionnaire
The Ministry of Health is embarking on a refresh of content in the New Zealand Health Survey (NZHS), which has been in continuous operation in its current form since 2011. The purpose of this refresh is to update NZHS content so that it better meets users' needs, while shortening the survey's length to minimise burden on respondents. This questionnaire marks the beginning of this refresh, and seeks detailed feedback from stakeholders on how useful they find the current indicators... MoreOpened 26 June 2019 -
Adult New Zealand Health Survey Stakeholder Feedback Questionnaire
The Ministry of Health is embarking on a refresh of content in the New Zealand Health Survey (NZHS), which has been in continuous operation in its current form since 2011. The purpose of this refresh is to update NZHS content so that it better meets users' needs, while shortening the survey's length to minimise burden on respondents. This questionnaire marks the beginning of this refresh, and seeks detailed feedback from stakeholders on how useful they find the current indicators and... MoreOpened 26 June 2019 -
Proposed prostate cancer quality performance indicators for clinical review
We are seeking your clinical review of proposed quality performance indicators for prostate cancer. The Ministry and the National Urological Cancer Working Group (the Working Group) have worked together to develop a set of proposed quality performance indicators (QPIs) for prostate cancer. The proposed indicators have been selected to measure performance and drive quality improvement in prostate cancer diagnosis and treatment services . The Working Group has identified a set of... MoreOpened 20 May 2019 -
Health & Disability Workforce Strategic Priorities
The Health Workforce directorate in the Ministry of Health is working to develop a small number of defined priorities to guide improvement actions for the New Zealand health and disability workforce during the period 2019-2024. To support this work, please fill out this survey for ranking and rating the 18 potential strategic priorities. The aim of the survey is to establish an accurate picture of people's perspectives through comparing and cross-referencing the results of the ranking... MoreOpened 16 May 2019 -
New Zealand Obstetric Ultrasound Guidelines
The draft New Zealand Obstetric Ultrasound Guidelines have been developed by a working group of sector clinical experts, with support from the Ministry of Health. New Zealand Obstetric Ultrasound Guidelines: Consultation document (Word, 8.0 MB) New Zealand Obstetric Ultrasound Guidelines: Consultation document (PDF, 2.8 MB) The guidelines are a key recommendation of the Maternity Ultrasound Advisory Group, which was a sub-group of the National Maternity Monitoring... MoreOpened 26 March 2019 -
Natural health products industry questionnaire
Purpose The Ministry of Health and the Ministry for Primary Industries are asking the natural health products industry to complete this questionnaire so that we can better understand business profiles. This will help us minimise the costs and maximise the benefits as far as is practical when developing regulatory approaches, while also protecting consumers. Process If you are part of the natural health products industry, we would be grateful if you could help us by completing... MoreOpened 25 March 2019 -
Code of Practice for Industrial Radiography: Draft for consultation
The Radiation Safety Act 2016 came fully into force on 7 March 2017. The Act is administered by the Ministry of Health’s Office of Radiation Safety. The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the requirements are often very technical. The Act therefore authorises the issuing of codes of practice to set out more detailed requirements relating to individual areas of practice. This code relates to... MoreOpened 5 March 2019 -
HISO 10072.2:2019 Bowel Screening Histology Data Standard – Draft for public comment
You are invited to review and provide comment on the draft Bowel Screening Histology Data Standard. The National Bowel Screening Programme is a free programme for men and women aged 60–74 years eligible for publically funded health care. The primary objective of bowel screening is to reduce the mortality rate by diagnosing and treating bowel cancer at an earlier more treatable stage. A new system, called the National Screening Solution, is currently in development and will receive... MoreOpened 28 February 2019 -
Therapeutic Products Christchurch Forum Registration
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. MoreOpened 21 February 2019 -
Second round of consultation on the proposed donation and surrogacy guidelines
This is a second round of consultation, following our consultation in 2017, on ACART’s proposed changes to the guidelines for family gamete donation, embryo donation, the use of donated eggs with donated sperm (donated eggs/donated sperm) and clinic-assisted surrogacy (collectively, the Donation Guidelines review). ACART is inviting submissions on three matters it has reconsidered since the first round of consultation. Although ACART has confirmed its intention to rescind the mandatory... MoreOpened 14 February 2019 -
Code of Practice for the Safe Transport of Radioactive Material
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the safe transport of radioactive material by road, rail, sea and air. The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the requirements are often very technical. The Act therefore authorises the issuing of codes of practice to set out more detailed requirements relating to individual... MoreOpened 18 January 2019 -
Therapeutic Products - Events Registration of Interest
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. MoreOpened 14 December 2018 -
Therapeutic Products Information Forum Registration
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. MoreOpened 14 December 2018 -
Therapeutic Products Regulatory Scheme: Online Consultation
Consultation A Therapeutic Products Bill (the Bill) is being developed to replace the Medicines Act 1981 (and its associated regulations) and establish a new regulatory scheme for therapeutic products. This consultation document is intended to be read alongside an exposure draft of the Bill. It provides information on the policy and details contained in the exposure draft to help inform submissions on the draft Bill. The purpose of this consultation document ... MoreOpened 14 December 2018 -
Hearing the stories of those harmed by surgical mesh
As part of its response to ongoing concerns with the use of surgical mesh, the Ministry of Health is wanting to provide an opportunity for people who have been harmed by surgical mesh and their families/whānau to tell their stories. It is important that any such opportunity is inclusive and supportive of people’s different needs and situations. Therefore, we would like to hear from those who are interested in telling their story, about how they would like to do this. You could be... MoreOpened 29 November 2018 -
Guidance for best practice management - National Bowel Screening Programme
The National Bowel Screening Programme (NBSP) is a significant investment in reducing disease and death from one of New Zealand’s biggest cancer killers. The NBSP is our first screening programme for both men and women and, when fully implemented, is expected to detect 500 to 700 cancers every year, in the early stages. The development of these clinical guidelines aims to embed best practice clinical management across the screening pathway and ensure quality and consistency. MoreOpened 26 November 2018
127 results.
Page 4 of 5